Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
2
|
| pubmed:dateCreated |
1994-5-27
|
| pubmed:abstractText |
Structural models for the eukaryotic cell cycle control protein p34 from human, S. pombe and S. cerevisiae have been derived from the crystallographic coordinates of the cAMP-dependent protein kinase (cAPK) catalytic subunit (active conformation) and compared with the structure of inactive CDK2 apoenzyme. Differences between the p34 and cAPK catalytic sites provide a possible explanation for their different substrate specificities. The p34 models localize Tyr15 and Thr14 close to the sites of catalysis and substrate recognition where their phosphorylation could inhibit p34 kinase activity either by blocking MgATP or substrate binding. The conserved sequences PSTAIRE and LYLIFEFL are both close to the catalytic site and accessible on the protein surface available to mediate interactions with other proteins. It is predicted that p34 has an active-site cleft composed almost entirely of sequences common to all protein kinases and sequences unique to the p34 protein family. Genetic and biochemical analyses of p34 have shown that it interacts extensively with a number of other proteins. The model allows the relative disposition of these sites of mutation to each other and to the sites of catalysis and substrate recognition to be appreciated. Surface regions on p34 that are important for function have been identified. These sites identify residues that may interact with p13suc1, cyclin, p107wee1 and p80cdc25.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Feb
|
| pubmed:issn |
0269-2139
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
7
|
| pubmed:geneSymbol |
cdc13,
cdc2,
cdc25,
suc1,
wee1
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
243-53
|
| pubmed:dateRevised |
2009-11-19
|
| pubmed:meshHeading |
pubmed-meshheading:8170927-Amino Acid Sequence,
pubmed-meshheading:8170927-Apoenzymes,
pubmed-meshheading:8170927-Binding Sites,
pubmed-meshheading:8170927-CDC2 Protein Kinase,
pubmed-meshheading:8170927-Cell Cycle,
pubmed-meshheading:8170927-Computer Simulation,
pubmed-meshheading:8170927-Consensus Sequence,
pubmed-meshheading:8170927-Fungal Proteins,
pubmed-meshheading:8170927-Genes,
pubmed-meshheading:8170927-Genes, Fungal,
pubmed-meshheading:8170927-Humans,
pubmed-meshheading:8170927-Models, Molecular,
pubmed-meshheading:8170927-Molecular Sequence Data,
pubmed-meshheading:8170927-Protein Conformation,
pubmed-meshheading:8170927-Protein Structure, Tertiary,
pubmed-meshheading:8170927-Saccharomyces cerevisiae,
pubmed-meshheading:8170927-Schizosaccharomyces,
pubmed-meshheading:8170927-Species Specificity
|
| pubmed:year |
1994
|
| pubmed:articleTitle |
Mutational analysis supports a structural model for the cell cycle protein kinase p34.
|
| pubmed:affiliation |
Laboratory of Molecular Biophysics, Oxford University, UK.
|
| pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|